Core Insights - Willis Towers Watson (WTW) reported a revenue of $2.22 billion for Q1 2025, reflecting a year-over-year decline of 5% and an EPS of $3.13, down from $3.29 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $2.31 billion, resulting in a surprise of -3.96%, while the EPS also missed the consensus estimate of $3.20 by -2.19% [1] Revenue Breakdown - Health, Wealth and Career segment revenue was $1.17 billion, below the estimated $1.25 billion, marking a year-over-year decline of 12.8% [4] - Risk and Broking segment revenue matched the estimate at $1.03 billion, showing a year-over-year increase of 5% [4] - Total segment revenue was $2.19 billion, compared to the average estimate of $2.28 billion, indicating a year-over-year change of -5.3% [4] - Reimbursable expenses and other revenue was reported at $21 million, below the average estimate of $25.73 million, with no year-over-year change [4] Operating Income - Risk and Broking segment operating income was $226 million, exceeding the average estimate of $219.91 million [4] - Health, Wealth and Career segment operating income was $311 million, below the estimated $325.49 million [4] Stock Performance - Over the past month, shares of Willis Towers Watson have returned -3.8%, compared to a -5.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Willis Towers Watson (WTW) reported quarterly earnings of $3.13 per share, missing the Zacks Consensus Estimate of $3.20 per share, and down from $3.29 per share a year ago, representing an earnings surprise of -2.19% [1] - The company posted revenues of $2.22 billion for the quarter, missing the Zacks Consensus Estimate by 3.96%, and down from $2.34 billion year-over-year [2] - The stock has added about 4% since the beginning of the year, contrasting with the S&P 500's decline of -8.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.72 on revenues of $2.28 billion, and for the current fiscal year, it is $16.76 on revenues of $9.77 billion [7] - The estimate revisions trend for WTW is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Insurance - Brokerage industry, to which WTW belongs, is currently in the top 38% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, Ryan Specialty Group, is expected to report quarterly earnings of $0.39 per share, reflecting a year-over-year change of +11.4% [9]

Core Insights - WTW reported a solid start to 2025, with results aligning with expectations and progress on strategic goals [2] - The company is focused on growth, efficiency, and margin expansion amid economic uncertainty [2] Consolidated Results - Revenue for Q1 2025 was $2.22 billion, a decrease of 5% from $2.34 billion in Q1 2024; on a constant currency basis, revenue decreased by 4%, but organic revenue grew by 5% [3][5] - Income from operations increased by 54% to $432 million, with an operating margin of 19.4%, up 740 basis points year-over-year [3][6] - Net income rose to $239 million, a 23% increase from $194 million in the prior year [3][6] - Diluted EPS increased by 27% to $2.33, while adjusted diluted EPS remained stable at $3.13 [3][6] Segment Highlights Health, Wealth & Career (HWC) - HWC segment revenue was $1.17 billion, down 13% year-over-year; however, organic growth was 3% [9][10] - Operating income decreased by 7% to $311 million, with an operating margin of 26.7%, up 160 basis points [9][10] Risk & Broking (R&B) - R&B segment revenue increased by 5% to $1.03 billion, with organic growth also at 7% [11][12] - Operating income rose by 11% to $226 million, and operating margin improved to 22.0%, up 120 basis points [11][12] Cash Flow and Capital Allocation - Cash flows used in operating activities were $(35) million, compared to $24 million in the prior year; free cash flow was $(86) million, down from $(36) million [7][8] - The company repurchased 607,221 shares for $200 million during the quarter [8] Financial Considerations - The company expects share repurchases of approximately $1.5 billion, subject to market conditions [14] - Anticipated foreign currency impact on adjusted diluted earnings per share is expected to be neutral in 2025 [14]

Revenue Performance - Revenue for Q1 2025 was $2.22 billion, a decrease of 5% compared to $2.34 billion in Q1 2024, with organic revenue growth of 5%[6] - Total revenue for the three months ended March 31, 2025, was $2,223 million, a decrease of 5% compared to $2,341 million in the same period of 2024[45] - The Health, Wealth & Career segment reported revenue of $1.17 billion, down 13% year-over-year, but achieved organic growth of 3%[10] - The Risk & Broking segment generated revenue of $1.03 billion, an increase of 5% year-over-year, with organic growth of 7%[12] - Health, Wealth & Career segment revenue was $1,158 million, down 13% from $1,327 million year-over-year, with an organic change of 3%[45] - Risk & Broking segment revenue increased by 5% to $1,027 million from $978 million, with an organic growth of 8%[45] Profitability Metrics - Net Income for Q1 2025 increased to $239 million, up 23% from $194 million in Q1 2024[7] - Diluted EPS for Q1 2025 was $2.33, reflecting a 27% increase from $1.83 in the prior year[8] - Operating Margin improved to 19.4%, up 740 basis points from 12.0% in Q1 2024[4] - Adjusted Operating Income for Q1 2025 was $480 million, a slight decrease of 1% from $483 million in Q1 2024[4] - Income from operations increased to $432 million for Q1 2025, compared to $280 million in Q1 2024, reflecting a growth of 54.3%[59] - Adjusted net income for Q1 2025 was $316 million, slightly down from $325 million in Q1 2024, indicating a decrease of 2.8%[52] - The company reported a net income attributable to WTW of $235 million for Q1 2025, up from $190 million in Q1 2024, reflecting a growth of 23.7%[59] Cash Flow and Liquidity - Free cash flow for Q1 2025 was $(86) million, a decrease of $50 million compared to $(36) million in Q1 2024, primarily due to the sale of TRANZACT[9] - Free cash flow for the three months ended March 31, 2025, was negative at $(86) million, compared to $(36) million in the same period of 2024[57] - Net cash used in operating activities was $(35) million in 2025, compared to $24 million in 2024, indicating a significant decline in cash flow from operations[63] - Net cash used in investing activities increased to $(84) million in 2025 from $(74) million in 2024, showing a rise of 13.5% in cash outflow for investments[63] - Net cash from financing activities was $24 million in 2025, a decrease from $1,556 million in 2024, indicating a substantial reduction in financing cash flow[63] - Total cash, cash equivalents, and restricted cash at the end of the period was $4,983 million, down from $5,251 million in the previous year, reflecting a decrease of 5.1%[65] Assets and Liabilities - Total assets as of March 31, 2025, were $28,064 million, an increase from $27,681 million as of December 31, 2024[60] - Total liabilities increased to $19,850 million as of March 31, 2025, compared to $19,664 million at the end of 2024[60] Taxation - The U.S. GAAP tax rate for Q1 2025 was 21.5%, compared to 19.9% in Q1 2024, indicating an increase in the effective tax rate[56] - Adjusted income tax rate is calculated based on adjusted income before taxes, providing a more accurate reflection of the tax rate incurred[33] Strategic Outlook - The company anticipates future growth driven by strategic acquisitions and ongoing operational transformation initiatives[37] - The company faces significant risks including economic conditions, regulatory changes, and competition that could impact future performance[38] Shareholder Activities - The company plans to repurchase approximately $1.5 billion in shares, subject to market conditions[15] - The company repurchased shares worth $200 million in 2025, up from $101 million in 2024, representing a 98% increase in share repurchase activity[63]

Core Insights - Willis Towers Watson (WTW) reported fourth-quarter 2024 adjusted earnings of $8.13 per share, surpassing the Zacks Consensus Estimate by 1.5% and reflecting a 9% year-over-year increase [2] - The company achieved adjusted consolidated revenues of $3 billion, a 4% increase year-over-year, although it fell short of the Zacks Consensus Estimate by 0.3% [3] - The total costs of providing services decreased by 0.04% year-over-year to $2.1 billion, contributing to a 10% increase in adjusted operating income to $1 billion [4] Financial Performance - Adjusted EBITDA rose to $1.1 billion, marking an 8.6% year-over-year increase, with an adjusted EBITDA margin of 38.6%, expanding by 150 basis points [5] - For the full year, adjusted earnings reached $16.93 per share, exceeding the Zacks Consensus Estimate by 1% and reflecting a 17% year-over-year increase [15] - Cash and cash equivalents as of December 31, 2024, were $1.8 billion, up 32.7% from the end of 2023, while long-term debt increased by 16.2% to $5.3 billion [11] Segment Performance - Health, Wealth & Career segment revenues totaled $1.8 billion, a 3% year-over-year increase, but missed the Zacks Consensus Estimate by 1.2% [6] - Risk & Broking segment revenues rose to $1.1 billion, a 6% year-over-year increase, although it also fell short of the Zacks Consensus Estimate by 0.1% [8] Future Outlook - The company anticipates share repurchases of $1.5 billion and projects an average annual margin expansion of 100 basis points over the next three years in the Risk & Broking segment [13] - WTW expects cash outflows in 2025 related to the settlement of accrued costs from the Transformation program, which concluded in 2024 [14] - Estimates for the stock have trended downward, with a consensus estimate shift of -8.56% over the past month, leading to a Zacks Rank of 5 (Strong Sell) [16][18]